PerkinElmer Opens New Facility in Singapore
Underscores Commitment to Growth in Singapore with Office in JTC MedTech Hub
WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the opening of a new office facility in Singapore.
WHEN & WHERE: PerkinElmer held a ribbon cutting ceremony to commemorate the opening of its facility in JTC MedTech Hub, a dedicated facility for medical technology manufacturers and service providers located within the MedTech Park. Robert Friel, PerkinElmer’s chairman and chief executive officer, and Prahlad Singh, president and chief operating officer, hosted government officials, customers, partners and employees at the event.
The ceremony was graced by guest of honor, Dr. Koh Poh Koon, Senior Minister of State for Ministry of Trade and Industry.
WHY: “Opening this new site in JTC MedTech Hub reaffirms PerkinElmer’s commitment to operating our business and growing our customer base here in Singapore and throughout Southeast Asia,” said Robert Friel, chairman and chief executive officer of PerkinElmer. “We offer a broad portfolio of solutions and services to our customers to help them solve challenges within the life sciences, food, diagnostics and applied markets.”
PerkinElmer’s facility at JTC MedTech Hub serves as a global manufacturing site for the Company’s detection and analytical instruments, specializing in a variety of advanced applications, including atomic absorption, mass spectrometry and gas chromatography. The site also houses two demonstration laboratories in which customers can have hands-on experience with PerkinElmer’s technologies. Employees at this facility handle a variety of functions including manufacturing, sales, service, IT, finance customer care, logistics, compliance and order management.
MORE: PerkinElmer first established its presence in Singapore in 1997 and currently has a total of more than 340 employees across two locations. Approximately 320 employees are located at the JTC MedTech Hub facility, which offers solutions to research professionals and laboratories in the environmental, pharmaceutical, semiconductor, petrochemical, life sciences and clinical diagnostics markets.There are also about 20 PerkinElmer employees in the east of Singapore who serve customers in the autoimmune, allergen, and infectious disease markets.
PerkinElmer enables scientists, researchers and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, we deliver unique solutions to serve the diagnostics, life sciences, food and applied markets. We strategically partner with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Our dedicated team of 12,500 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the wellbeing and longevity of people globally. The Company reported revenue of approximately $2.8 billion in 2018, serves customers in more than 150 countries, and is a component of the S&P 500 index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.
+1-781-663-5728 or +1 781-913-0233